ASP同位素公司與Isotopia宣佈達成釓-160供應協議，以加速用於先進癌症治療的鋱-161生產ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies

動脈網

2025/06/02

PETACH TIKVA,佩塔提克瓦，Israel以色列,，June 2, 20252025年6月2日/PRNewswire/ -- ASP Isotopes Inc. (NASDAQ:/PRNewswire/ -- ASP Isotopes Inc.（納斯達克：ASPI亞太安全合作理事會) and Isotopia Molecular Imaging Ltd. have entered into...

網頁鏈接

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2540908763"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2540908763\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2540908763?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-06-02 15:00","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2540908763","market":"us","top_or_hot":-1,"title":"ASP同位素公司與Isotopia宣佈達成釓-160供應協議，以加速用於先進癌症治療的鋱-161生產ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies","media":"動脈網","content":"<div>\n<p>PETACH TIKVA,佩塔提克瓦，Israel以色列,，June 2, 20252025年6月2日/PRNewswire/ -- ASP Isotopes Inc. (NASDAQ:/PRNewswire/ -- ASP Isotopes Inc.（納斯達克：ASPI亞太安全合作理事會) and Isotopia Molecular Imaging Ltd. have entered into...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602152716950b4a53&s=b\">網頁鏈接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ASP同位素公司與Isotopia宣佈達成釓-160供應協議，以加速用於先進癌症治療的鋱-161生產ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nASP同位素公司與Isotopia宣佈達成釓-160供應協議，以加速用於先進癌症治療的鋱-161生產ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">動脈網</strong><span class=\"h-time small\">2025-06-02 15:00</span>\n</p>\n</h4>\n</header>\n<article>\n<div>\n<p>PETACH TIKVA,佩塔提克瓦，Israel以色列,，June 2, 20252025年6月2日/PRNewswire/ -- ASP Isotopes Inc. (NASDAQ:/PRNewswire/ -- ASP Isotopes Inc.（納斯達克：ASPI亞太安全合作理事會) and Isotopia Molecular Imaging Ltd. have entered into...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602152716950b4a53&s=b\">網頁鏈接</a>\n\n</div>\n\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602152716950b4a53&s=b\">動脈網</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4109","symbol_name":"特種化學制品","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602152716950b4a53&s=b","article_id":"2540908763","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602152716950b4a53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2540908763","pubTimestamp":1748847600,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"This partnership addresses longstanding supply challenges for Gd-160, enabling Isotopia to advance Tb-161-based therapies for prostate cancer, neuroendocrine tumors, and other malignancies.該合作伙伴關係解決了長期以來的Gd-160供應挑戰，使Isotopia能夠推進基於Tb-161的前列腺癌、神經內分泌腫瘤和其他惡性腫瘤療法的發展。過去兩年中，Isotopia持續生產鑥-177，並為其臨床試驗維持每周一次的鋱-161生產。Tb-161's Auger electrons induce double-strand DNA breaks in cancer cells, offering potential advantages over Lu-177 and alpha-e","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4109":"特种化学制品","AAQC":"Accelerate Acquisition Corp","ASPI":"ASP Isotopes Inc."},"translate_title":"ASP Isotopes and Isotopia announce gadolinium-160 supply agreement to accelerate terbium-161 production for advanced cancer therapy ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ASPI":0.9,"AAQC":1},"content_text":"PETACH TIKVA,佩塔提克瓦，Israel以色列,，June 2, 20252025年6月2日/PRNewswire/ -- ASP Isotopes Inc. (NASDAQ:/PRNewswire/ -- ASP Isotopes Inc.（納斯達克：ASPI亞太安全合作理事會) and Isotopia Molecular Imaging Ltd. have entered into a strategic agreement to secure the supply of Gadolinium-160 (Gd-160), a critical precursor isotope for producing Terbium-161 (Tb-161), an emerging medical isotope with significant potential in targeted radiotherapeutics.）和Isotopia分子影像有限公司達成了戰略協議，以確保獲得生產鋱-161（Tb-161）所需的關鍵前體同位素釓-160（Gd-160）。鋱-161是一種新興的醫用同位素，在靶向放射治療領域具有重大潛力。This partnership addresses longstanding supply challenges for Gd-160, enabling Isotopia to advance Tb-161-based therapies for prostate cancer, neuroendocrine tumors, and other malignancies.該合作伙伴關係解決了長期以來的Gd-160供應挑戰，使Isotopia能夠推進基於Tb-161的前列腺癌、神經內分泌腫瘤和其他惡性腫瘤療法的發展。Under the agreement, ASP Isotopes will leverage its proprietary Quantum Enrichment technology to provide Isotopia with enriched Gd-160, a stable isotope essential for manufacturing Tb-161.根據協議，ASP同位素公司將利用其專有的量子富集技術，向Isotopia提供富集的釓-160（Gd-160），這是一種製造鋱-161（Tb-161）所必需的穩定同位素。The collaboration combines ASP Isotopes' expertise in large-scale isotope enrichment—previously demonstrated through its production of Ytterbium-176 (Yb-176)—with Isotopia's proven capabilities in commercial-scale medical isotope production. Isotopia has consistently manufactured Lutetium-177 (Lu-177) and maintained weekly Tb-161 production for its clinical trials over the past two years. .該合作結合了ASP Isotopes在大規模同位素富集方面的專業知識——此前通過生產鐿-176（Yb-176）得到了證明——以及Isotopia在商業規模醫療同位素生產中的成熟能力。過去兩年中，Isotopia持續生產鑥-177（Lu-177），並為其臨床試驗維持每周一次的鋱-161（Tb-161）生產。Paul Mann保羅·曼, CEO，首席執行官of ASP IsotopesASP同位素, emphasized the agreement's significance: 'By supplying Gd-160, we are eliminating a major bottleneck in the development of Tb-161 therapies. Our investment in enrichment technology positions us to support the radiopharmaceutical industry's growing demand for stable isotopes. This partnership accelerates the path to clinical adoption of Tb-161, which could redefine cancer treatment paradigms.' .強調了該協議的重要性：「通過供應釓-160，我們正在消除鋱-161療法開發中的一個主要瓶頸。我們對濃縮技術的投資使我們能夠支持放射性藥物行業對穩定同位素日益增長的需求。這一合作加快了鋱-161臨床應用的進程，這可能重新定義癌症治療模式。」Dr.博士Eli Shalom以利·沙洛姆, CEO of Isotopia，Isotopia首席執行官, highlighted Tb-161's therapeutic advantages: 'Tb-161's dual mechanism of action, including Auger electron emissions, enables precise targeting of micro-metastases while minimizing damage to healthy tissues. This partnership ensures a reliable Gd-160 supply chain, allowing us to scale production and advance our Tb-161-labeled drug candidates toward commercialization.，突出了Tb-161的治療優勢：「Tb-161的雙重作用機制，包括俄歇電子發射，能夠精準靶向微小轉移灶，同時將對健康組織的損害降至最低。此次合作確保了Gd-160供應鏈的可靠性，使我們能夠擴大生產規模，並推動我們的Tb-161標記藥物候選物邁向商業化。」We produce in our site in .我們在我們的站點生產。Israel以色列and shortly the production will start in our second site in很快，我們第二個地點的生產將開始Indianapolis印第安納波利斯in the US.'在美國。Tb-161's Auger electrons induce double-strand DNA breaks in cancer cells, offering potential advantages over Lu-177 and alpha-emitting isotopes. This precision aligns with the oncology field's shift toward targeted radiotherapeutics, which improve efficacy and reduce side effects. The agreement comes as global interest in radiopharmaceuticals surges, driven by their ability to deliver localized radiation therapy via tumor-seeking molecules. .Tb-161的俄歇電子在癌細胞中誘導雙鏈DNA斷裂，相比Lu-177和α發射同位素具有潛在優勢。這種精準性符合腫瘤學領域向靶向放射治療的轉變，可提高療效並減少副作用。該協議正值全球對放射性藥物的興趣激增之際，其背後推動力是這些藥物能夠通過靶向腫瘤的分子提供局部放射治療。About ASP Isotopes Inc.關於ASP同位素公司ASP Isotopes Inc. specializes in advanced isotope separation technologies, including its proprietary Aerodynamic Separation Process and Quantum Enrichment, which produce stable isotopes without radioactive waste. The company's initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries.ASP同位素公司專注於先進的同位素分離技術，包括其專有的空氣動力分離工藝和量子富集技術，這些技術可以在不產生放射性廢料的情況下生產穩定同位素。該公司最初的重心是為醫療保健和技術行業生產和商業化高丰度同位素。The Company has isotope enrichment facilities in .公司擁有位於 的同位素濃縮設施。Pretoria, South Africa南非比勒陀利亞. For more information, please visit欲了解更多信息，請訪問www.aspisotopes.comwww.aspisotopes.com.。About Isotopia Molecular Imaging Ltd.關於Isotopia分子影像有限公司Isotopia is a global leader in medical isotope production, with facilities inIsotopia 是醫療同位素生產的全球領導者，在以下地區擁有設施：Israel以色列,，Europe歐洲, and the U.S. Its integrated platform includes cyclotrons, Lu-177 and Tb-161 production sites, and sterile manufacturing capabilities. The company collaborates with researchers and clinicians to develop novel radiopharmaceuticals for diagnostics and targeted therapy.，以及美國。其集成平台包括迴旋加速器、Lu-177 和 Tb-161 生產基地以及無菌製造能力。該公司與研究人員和臨床醫生合作，開發用於診斷和靶向治療的新型放射性藥物。This partnership positions both companies at the forefront of the radiopharmaceutical revolution, with the potential to expand treatment options for cancer patients worldwide.這一合作伙伴關係使兩家公司處於放射性藥物革命的前沿，有望為全球癌症患者擴展治療選擇。Contact:聯繫：eshalom@isotopia-global.com艾沙洛姆@同位素全球.comLogo -標誌 -https://mma.prnewswire.com/media/2659964/Isotopia_Logo.jpghttps://mma.prnewswire.com/media/2659964/Isotopia_Logo.jpgWANT YOUR COMPANY'S NEWS想要你公司的新聞嗎FEATURED ON PRNEWSWIRE.COM?榮登PRNEWSWIRE.COM？440k+44萬+Newsrooms &新聞編輯室 &Influencers影響者9k+9k+Digital Media數字媒體Outlets插座270k+27萬+Journalists記者Opted In已選擇加入GET STARTED開始使用","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}